Gozes Y, Epstein N, Halmann M, Bino T, Rosenberg H, Kobiler D
Dev Biol Stand. 1987;66:447-55.
B cell growth factor (BCGF) is a lymphokine (LK) primarily produced and secreted by activated T cells. This LK induces proliferation of B cells in culture and can maintain continuous growth of human B cells. One of the putative uses of this factor might be the establishment of monoclonal B cell lines which secrete specific antibodies. These antibodies could be used for passive immunization or in vivo immunodiagnostics. As conventional mitogen activation of T cells induces the secretion of many factors, some of them with opposite effects, the approach taken by us and others was to establish monoclonal hybridomas which produce constitutively a single factor. Such a human T-T cell hybridoma (TH-5), has been established and is growing and secreting constitutively BCGF for the tested 18 months. This BCGF induces proliferation of human B-cells without the requirement of B cell preactivation. No secretion of interleukin-2 or gamma-interferon by this hybridoma was detected. Furthermore, no influence of this factor was detected on T cells. Under optimal growth conditions, the generation time of this hybridoma is 16 hours and it reaches a maximum concentration of 3 X 10(6) cells/ml. The hybridoma cells could grow in serum-free-media and secrete BCGF for a limited time. The produced BCGF was found to be stable for the four tested months at -20 degrees C, at least one week at 4 degrees C and several hours at 37 degrees C. Its activity was destroyed at pH 2.(ABSTRACT TRUNCATED AT 250 WORDS)
B细胞生长因子(BCGF)是一种主要由活化T细胞产生和分泌的淋巴因子。这种淋巴因子可在培养中诱导B细胞增殖,并能维持人B细胞的持续生长。该因子的一种可能用途或许是建立分泌特异性抗体的单克隆B细胞系。这些抗体可用于被动免疫或体内免疫诊断。由于传统的T细胞有丝分裂原激活会诱导多种因子的分泌,其中一些因子具有相反的作用,我们和其他人所采用的方法是建立能持续产生单一因子的单克隆杂交瘤。这样一个人T - T细胞杂交瘤(TH - 5)已经建立,在经过测试的18个月里持续生长并分泌BCGF。这种BCGF可诱导人B细胞增殖,而无需B细胞预先激活。未检测到该杂交瘤分泌白细胞介素 - 2或γ - 干扰素。此外,未检测到该因子对T细胞有影响。在最佳生长条件下,该杂交瘤的倍增时间为16小时,其最大浓度可达3×10⁶个细胞/毫升。杂交瘤细胞可在无血清培养基中生长,并在有限时间内分泌BCGF。所产生的BCGF在-20℃下经测试的四个月内保持稳定,在4℃下至少稳定一周,在37℃下稳定数小时。其活性在pH 2时被破坏。(摘要截短于250字)